What to Know about the Aprocitentan Approval for Resistant Hypertension, with Michael Weber, MD

Michael Weber, MD, lead of the PRECISION trial, discusses the significance of the aprocitentan (Tryvio) approval and key points for providers who may have patients with uncontrolled hypertension.

Related Keywords

New York ,United States ,Aprocitentan Tryvio ,Michael Weber ,Medtronic ,Ablative Solutions ,Cardiovascular Medicine ,State University ,Standard Error ,